V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220020788 | 220008088 | 1.6 | 53.1 | Curative (C) | 2014-07-08 | 2014-10-13 | ATG + Busulfan + Fludarabine | N | N | 220030766 | ATG + BUSULFAN + FLUDARABINE |
| 220020789 | 220008089 | 1.75 | 47.3 | Curative (C) | 2016-11-29 | 2016-11-30 | ATG + Busulfan + Fludarabine | N | N | 220030766 | ATG + BUSULFAN + FLUDARABINE |
| 220020791 | 220008091 | 0 | null | Curative (C) | 2017-11-13 | 2018-02-18 | ATG + Busulfan + Fludarabine | 2 | N | 220030784 | ATG + BUSULFAN + FLUDARABINE |
| 220020792 | 220008110 | 1.7 | 67.9 | Curative (C) | 2014-01-13 | 2014-01-13 | Idarubicin+Tretinoin Spanish Crse2 | Y | N | 220030849 | IDARUBICIN + TRETINOIN |
| 220020793 | 220008117 | null | 65.9 | null | null | 2018-07-19 | FLAG | Y | null | 220030880 | FLAG |
| 220020795 | 220008136 | 1 | 119 | Disease modification (D) | null | 2017-09-24 | FLAG | null | null | 220030936 | FLAG |
| 220020796 | 220008143 | 1.67 | 57 | Adjuvant (A) | null | 2018-11-25 | BOSUTINIB | null | N | 220030955 | BOSUTINIB |
| 220020798 | 220008154 | null | null | Curative (C) | 2014-05-17 | 2014-07-03 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220030962 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220020799 | 220008162 | 1.77 | 68 | Disease modification (D) | 2017-12-31 | 2018-08-12 | RUXOLITINIB | null | N | 220030983 | RUXOLITINIB |
| 220020800 | 220008164 | 1.67 | 66.1 | Curative (C) | null | 2019-04-22 | CYCLOPHOSPHAMIDE + FLUDARABINE | 2 | N | 220030991 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220020802 | 220008169 | null | 46.7 | Not known (9) | 2013-08-03 | 2013-08-08 | Idarubicin+Tretinoin Spanish Crse4 | 02 | N | 220031002 | IDARUBICIN + TRETINOIN |
| 220020803 | 220008175 | 1.62 | null | Curative (C) | 2018-04-15 | 2018-05-08 | RUXOLITINIB | null | null | 220031027 | RUXOLITINIB |
| 220020804 | 220014462 | 0 | 52.5 | Curative (C) | 2014-04-10 | 2015-02-02 | Methotrexate intrathecal | N | N | 220031045 | METHOTREXATE INTRATHECAL |
| 220020805 | 220008180 | null | null | Disease modification (D) | 2016-11-21 | 2016-11-23 | CYCLOPHOSPHAMIDE | null | null | 220031046 | CYCLOPHOSPHAMIDE |
| 220020806 | 220008191 | 1.8 | 69.85 | Curative (C) | 2018-05-14 | 2018-06-19 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 220031111 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220020807 | 220021553 | 1.71 | 65 | Palliative (P) | 2017-04-02 | 2017-04-02 | FLAG | 02 | N | 220031113 | FLAG |
| 220020808 | 220008210 | 0 | 62.2 | Curative (C) | null | 2016-12-23 | Cyclophosphamide+Fludara+TBI Allo | N | N | 220031213 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 220020809 | 220014482 | 0 | 59 | Curative (C) | 2017-01-30 | 2017-05-18 | AML Int Guide ADE 8+3+5 (2) | N | N | 220031254 | ADE |
| 220020810 | 220008236 | null | 0 | Curative (C) | 2016-02-22 | 2016-02-24 | Triple Intrathecal | 2 | N | 220031299 | TRIPLE INTRATHECAL |
| 220020811 | 220017913 | 1.67 | 97.8 | Curative (C) | 2014-12-20 | 2015-01-28 | IDARUBICIN + TRETINOIN | 02 | N | 220031302 | IDARUBICIN + TRETINOIN |
| 220020812 | 220008253 | 1.6 | null | Curative (C) | 2015-07-29 | 2015-10-21 | Triple Intrathecal | 2 | N | 220031392 | TRIPLE INTRATHECAL |
| 220020813 | 220008263 | 1.65 | 74.8 | Curative (C) | 2018-01-22 | 2018-02-03 | AML Int Guide ADE 8+3+5 (2) | null | N | 220031415 | ADE |
| 220020814 | 220008272 | 1.66 | 74.5 | Curative (C) | 2015-02-23 | 2015-02-23 | RUXOLITINIB | 02 | N | 220031435 | RUXOLITINIB |
| 220020815 | 220014507 | 1.58 | 60.9 | Curative (C) | 2018-07-30 | 2018-07-31 | FLAG | N | N | 220031482 | FLAG |
| 220020816 | 220008288 | null | 0 | Palliative (P) | 2018-03-30 | 2018-07-17 | BOSUTINIB | 02 | Y | 220031491 | BOSUTINIB |
| 220020817 | 220008311 | 1.83 | 147 | Curative (C) | 2012-12-04 | 2014-05-20 | FLAG | N | N | 220031587 | FLAG |
| 220020818 | 220008318 | 1.67 | 54.6 | Disease modification (D) | null | 2014-12-13 | BOSUTINIB | null | null | 220031606 | BOSUTINIB |
| 220020819 | 220008321 | 0 | 43.4 | Disease modification (D) | 2013-06-21 | 2013-07-26 | Triple Intrathecal | N | N | 220031607 | TRIPLE INTRATHECAL |
| 220020820 | 220008328 | 1.86 | 66.8 | Palliative (P) | 2015-09-23 | 2015-12-16 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 2 | N | 220031621 | UKALL2014 |
| 220020821 | 220021560 | 1.62 | 63 | Curative (C) | 2016-12-04 | 2016-12-13 | GemCarbo Days 1+8 | 02 | N | 220031681 | ECX |
| 220020822 | 220008346 | 1.62 | 75 | Not known (9) | 2013-06-19 | 2013-06-30 | METHOTREXATE | null | null | 220031687 | GEMCARBO |
| 220020823 | 220008353 | 1.8 | 53 | Palliative (P) | 2017-12-29 | 2018-01-04 | FLUOROURACIL + OXALIPLATIN | N | N | 220031700 | UKALL2014 |
| 220020824 | 220017941 | 1.83 | 84.45 | Curative (C) | 2014-01-10 | 2014-01-10 | Docetaxel | N | N | 220031735 | IRINOTECAN + MDG |
| 220020825 | 220008362 | 1.57 | 78.6 | Disease modification (D) | 2014-07-23 | 2014-07-23 | Docetaxel 75mg/m2 (21 day) | 2 | N | 220031736 | FBC |
| 220020826 | 220008364 | 1.66 | 61.1 | Curative (C) | 2014-02-04 | 2015-04-19 | Cytarabine intrathecal | 2 | N | 220031746 | CYTARABINE INTRATHECAL |
| 220020827 | 220014542 | 1.55 | 93.8 | Curative (C) | 2016-10-15 | 2017-02-18 | IDARUBICIN | 02 | N | 220031774 | IDARUBICIN |
| 220020829 | 220008389 | 1.77 | 77.1 | Curative (C) | 2019-03-01 | 2019-03-01 | GemCarbo Days 1+8 | 2 | N | 220031813 | IRINOTECAN + MDG |
| 220020831 | 220017949 | 1.73 | 113.1 | Curative (C) | 2014-08-04 | 2014-08-13 | PACLITAXEL | 02 | N | 220031821 | PACLITAXEL |
| 220020832 | 220014553 | 1.67 | 66.4 | Curative (C) | 2017-09-25 | 2017-09-26 | Cytarabine intrathecal | N | N | 220031880 | CYTARABINE INTRATHECAL |
| 220020833 | 220008404 | 1.65 | 71.6 | null | 2016-02-24 | 2016-02-28 | Mitox + Tretinoin Spanish Course 3 | null | null | 220031901 | MITOXANTRONE |
| 220020834 | 220008409 | 1.72 | 100.4 | Curative (C) | 2013-12-17 | 2014-01-24 | PONATINIB | N | N | 220031924 | DOCETAXEL |
| 220020836 | 220008419 | 1.59 | 53.5 | Curative (C) | 2017-03-13 | 2017-03-15 | Fludarabine + Melphalan RIC Allo | null | null | 220031947 | DOCETAXEL |
| 220020837 | 220021564 | 1.64 | null | Disease modification (D) | 2014-11-03 | 2014-11-03 | CARBOPLATIN + PACLITAXEL | 2 | N | 220031967 | CARBOPLATIN + PACLITAXEL |
| 220020838 | 220008425 | 1.54 | 54 | Curative (C) | 2018-03-09 | 2018-03-09 | Alemtuzumab | 2 | N | 220031977 | ALEMTUZUMAB |
| 220020839 | 220008428 | 1.79 | null | Curative (C) | 2016-04-12 | 2016-04-26 | FLUDARABINE + MELPHALAN | 02 | N | 220031998 | OXALIPLATIN + MDG |
| 220020840 | 220008435 | 1.66 | 65.1 | Palliative (P) | null | 2017-08-03 | Mitoxantrone | null | null | 220032025 | MITOXANTRONE |
| 220020841 | 220008442 | 1.71 | 89 | Curative (C) | 2017-03-26 | 2017-03-28 | UKALL14- Intens/CNS Proph | null | null | 220032039 | CISPLATIN + GEMCITABINE |
| 220020842 | 220008447 | 1.77 | null | Curative (C) | 2017-04-28 | 2017-05-06 | Mitoxantrone | N | N | 220032050 | MITOXANTRONE |
| 220020843 | 220008449 | 1.78 | 67.7 | Curative (C) | 2017-09-28 | 2017-10-03 | ECX | null | N | 220032052 | CLOFARABINE + CYTARABINE |
| 220020844 | 220019865 | null | 86.2 | Palliative (P) | 2017-12-19 | 2017-12-19 | Docetaxel 75mg/m2 (21 day) | N | null | 220032064 | DOCETAXEL |